TapewireFind a company

person · Reporting owner

Yamagishi-Dressler Tomoko

Disclosed activity across 1 company

Tapewire entity
76100
SEC CIK
0001990968

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Evolus, Inc.

Report date August 22, 2025 · Filed August 26, 2025

Section 16 reporting ended · disclosed 2025-08-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect89,949 Reported balance After 2025-08-22 transaction · row 1
1 source row

Row 1 · 2025-08-22 · Sale · Disposed 5,722 · Balance 89,949

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 22, 2025 Filed Aug 26, 2025 18:26 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 5,722 $7.51 $42,972.22
Disclosure

SEC source: 0001570562-25-000105 · wk-form4_1756247187.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,949

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

Read SEC document
March 18, 2025 Filed Mar 20, 2025 18:27 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 4,536 $13.26 $60,124.68
Disclosure

SEC source: 0001570562-25-000052 · wk-form4_1742509629.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,671

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $13.1807 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:55 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 25,407 $0.00 Strike: $13.58 $0.00
Disclosure

SEC source: 0001570562-25-000044 · wk-form4_1741733699.xml · derivative · entry 3

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,407

Underlying: Common Stock · 25,407 shares

Expires 2035-03-07

F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:55 UTC Evolus, Inc. EOLS · Entity 5341 GrantPerformance Restricted Stock Units · Derivative 17,832 $0.00 $0.00
Disclosure

SEC source: 0001570562-25-000044 · wk-form4_1741733699.xml · derivative · entry 2

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,832

Underlying: Common Stock · 17,832 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:55 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 17,832 $0.00 $0.00
Disclosure

SEC source: 0001570562-25-000044 · wk-form4_1741733699.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,207

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:14 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 5,631 $15.85 $89,251.35
Disclosure

SEC source: 0001570562-24-000119 · wk-form4_1725480877.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,375

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 33,136 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001570562-24-000019 · wk-form4_1707521780.xml · derivative · entry 3

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,136

Underlying: Common Stock · 33,136 shares

Expires 2034-02-07

F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantPerformance Restricted Stock Units · Derivative 12,324 $0.00 $0.00
Disclosure

SEC source: 0001570562-24-000019 · wk-form4_1707521780.xml · derivative · entry 2

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,324

Underlying: Common Stock · 12,324 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 24,648 $0.00 $0.00
Disclosure

SEC source: 0001570562-24-000019 · wk-form4_1707521780.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,648

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:07 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 83,555 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001570562-23-000104 · wk-form4_1692835617.xml · derivative · entry 2

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,555

Underlying: Common Stock · 83,555 shares

Expires 2033-08-21

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:07 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 63,358 $0.00 $0.00
Disclosure

SEC source: 0001570562-23-000104 · wk-form4_1692835617.xml · nonDerivative · entry 1

Yamagishi-Dressler Tomoko · CIK 0001990968 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,358

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of August 21, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.